Disease treated5
|
Side-effects8,12,13
|
Relationship/communication with physician6,14,15
|
Gender9,16,17
|
Socioeconomic status6,10,17,19–21
|
Primary versus secondary disease prevention11,17,20,22
|
Dosing regimen/frequency5,8,22–24
|
Self-monitoring25
|
Age5,17
|
Level of education/health literacy9,26
|
Comorbidity10
|
Drug class10,12,13,27,28
|
Cost/co-payments6,8,20,22,29–31
|
Making time for appointments6,29
|
Ethnicity16
|
Depression10,14,32
|
Combination pill33–37
|
Routine place of care6,30
|
Stress/anxiety14
|
Minority status10
|
Diabetes10,17
|
|
Routine physician6,15,30
|
Forgetfulness6,14
|
Social support18
|
Duration of treatment20
|
|
Practitioner disagreement with guidelines14
|
Lack of understanding8,14,15,29
|
|
|
|
Coronary artery calcium (CAC) screening39
|
Alcohol consumption39
|
|
|
|
|
Patient beliefs/perception of drugs6,8,14,15,21
|
|